Nicolas Wolikow
Co-founder & CEO
at
Cure51

Nicolas Wolikow is a serial entrepreneur in Health Tech with a strong experience platforms and market places. Over 20 years operating as a Managing Director and revenue generation, digital business development and strategic leadership experiences within start-up and multinational firms. Managing P&L for business divisions exceeding $200M revenue. Cure51 is creating the first worldwide database of Exceptional Cancer Survivors.